On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Treatment of Parkinson’s Disease with Virtual Reality
In a recent article by Mahato et al. (2026), 250 individuals with Parkinson’s disease were assigned to either traditional physical therapy or virtual reality (VR)-based…
SPAN Q4 Meeting Reminder
The American Academy of Audiology’s State Policy Advocate Network (SPAN) will hold its fourth-quarter meeting next week, on October 28, 2026, from 8:00–9:00 pm ET….
Virginia Audiology Regulations Open for Public Comment
The Virginia Board of Audiology and Speech-Language Pathology published a proposed rule allowing for ABA certification to serve as an alternative pathway for audiology licensure….
